Remimazolam is an ultra short-acting benzodiazepine derivative that is structurally related to midazolam, with sedative-hypnotic activity. It is used in the induction and maintenance of sedation during short (<30 minute) procedures.


Product Name Remimazolam Besylate
CAS Number 1001415-66-2
Therapeutic Class Anesthetic Adjunct, Sedative, Benzodiazepines
Dosage Form Intravenous Injection
Availability Under Development
Regulatory Status